When analyzed agnostic to the intrinsic heterogeneity in gastric/GEJ adenocarcinoma, Lgr5 expression does not carry a statistically significant prognostic weight, although some prognostic significance is seen in early stage (I/II) patients [18, 19]. This evidence concerns the gene LGR5 and gastroesophageal junction adenocarcinoma.